Navigation Links
Sectra and Philips Complete Modality Transaction
Date:9/1/2011

SHELTON, Connecticut, September 1, 2011 /PRNewswire/ --

Sectra (NASDAQ OMX Stockholm: SECT B) has completed a mammography-modality deal with Royal Philips Electronics (AEX: PHI, NYSE: PHG). Philips will pay EUR 57.5 million in a cash-on-cash and debt-free basis and take over the acquired modality operation today, September 1, 2011.

"The deal with Philips will give us the resources we need to continue our efforts and expand our business. In Medical Systems, we can concentrate on our core business and aim for a larger share of the market growth for medical imaging IT systems, which is growing rapidly," says Torbjörn Kronander, President of Sectra's medical systems operation.

     (Logo: http://www.newscom.com/cgi-bin/prnh/20110627/465018 )

The divested operation represented 14% of the Sectra Group's net sales for fiscal year 2010/2011 and has approximately 110 employees. The transaction comprises Sectra's mammography-modality operations worldwide, except for Australia and New Zealand where Sectra will continue to sell and service the unique MicroDose mammography modality under a separate distribution agreement with Philips.

The agreement includes an additional earn-out of EUR 12.5 million, which will fall due if the agreed terms and conditions are achieved over a period of five years. This transaction, excluding the possible earn-out, is estimated to generate a capital gain in terms of earnings of about SEK 300 million after tax for Sectra.

Focus ON medical IT

Sectra is one of the world's largest suppliers of medical imaging IT solutions. Sectra provides radiology, mammography, orthopeadic and rheumatology clinics with medical-imaging IT solutions and services that enhance the efficiency of medical care, contribute to raising the quality of care a
'/>"/>

SOURCE Sectra
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
2. Cardiums InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
3. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
4. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
5. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
6. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
7. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
8. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
9. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
10. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
11. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014  aTyr ... today that rare disease expert John C. McKew ... Dr. McKew brings more than two decades of expertise ... National Institutes of Health, Wyeth Research and Genetics Institute, ... lead aTyr,s efforts to expand and translate its novel ...
(Date:10/20/2014)... Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... brings Q3 orders to $5.8 million and provides a good start ... North America and one in the ... new projects at record levels," said Peter Bruijns , President ... the end of Q3 than they have been for any complete ...
(Date:10/20/2014)... Rochelle, Virginia (PRWEB) October 20, 2014 ... of NDA Partners LLC, announced today that Ellen ... and legal support for the pharmaceutical industry, has ... and manager of its legal services practice. ... reports and expert witness and testimony, to top ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... PharmSource Information Services Inc., leads a videocast discussion with top ... and manufacturing to Asia. , ... ... convention in Atlanta, Georgia, Jim Miller, president of PharmSource Information ...
... REINACH, Switzerland, November 27 Arpida,announced today that it is ... The company says this is to be seen as a,consequence ... (FDA) advisory board on 20 November 2008 regarding the,approval of ... In the context of the FDA advisory board,s recommendation ...
... long envisioned sailing a spacecraft by the optical force of the ... fill even the oversized sails that have been tried. Now a ... & Applied Science has shown that the force of light ... is scaled to nano-proportions. , Their work opens the door ...
Cached Biology Technology:PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS 2Arpida to Restructure and Focus on Key Projects 2'The photon force is with us': Harnessing light to drive nanomachines 2
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
(Date:10/15/2014)... 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market releases photos and video of ... on Monday October 13 th . Gino ... and angel investor Mr. Chad A. Verdi rang ... NXT-ID thanked his investors and employees "for their work and dedication ...
(Date:10/14/2014)... 2014)—It,s been millions of years since T. rex ... by Ohio University scientists is breathing life back into ... dinosaur snouts. The research has important implications for how ... to enhance the sense of smell and cool their ... Ohio University doctoral student Jason Bourke, lead author of ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... space later this week, it will take along three ... genetic responses and their ability to cause disease change. ... STS-115 space shuttle mission scheduled for launch Aug. 27, ... aeruginosa and Candida albicans -- that have been identified ...
... a robot-controlled joystick, Johns Hopkins researchers have shown that the ... more likely it is to remember the lesson over the ... approaches for people who have lost motor abilities to brain ... work in the May 23 issue of PLoS Biology, the ...
... at high risk for breast cancer do not increase ... to a new analysis by researchers from UC Davis, ... Ontario, Canada. In addition, the researchers showed that tamoxifen ... as $1.3 million per year of life saved. The ...
Cached Biology News:Microscopic passengers to hitch ride on space shuttle 2Microscopic passengers to hitch ride on space shuttle 3Robotic joystick reveals how brain controls movement 2Robotic joystick reveals how brain controls movement 3Tamoxifen for breast cancer prevention does not benefit most women 2Tamoxifen for breast cancer prevention does not benefit most women 3
... Grade Thrombin is a highly purified preparation ... with appropriate vectors. The preparation is functionally ... is free of detectable contaminating proteases. Prepared ... by certified tests to be negative for ...
... proteomics demands the detection of very small ... the AXIMA-CFRplus with improved resolution (20,000) and ... increased confidence in protein identification. The AXIMA-CFRplus ... automated sample target handling and the ability ...
... Intended for users requiring mass ... AXIMA-LNR linear MALDI TOF Mass spectrometer ... QA/QC applications and for high performance ... oligonucleotide QA/QC, SNP analysis, protein detection, ...
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
Biology Products: